C. Lenich et al., THROMBIN STIMULATION OF PLATELETS INDUCES PLASMINOGEN ACTIVATION MEDIATED BY ENDOGENOUS UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, Blood, 90(9), 1997, pp. 3579-3586
Gene knockout mice studies indicate that urokinase-type plasminogen ac
tivator (U-PA) is importantly involved in fibrinolysis, but its physio
logic mechanism of action remains poorly understood. We postulated tha
t platelets may be involved in this mechanism, as they carry a novel r
eceptor for u-PA and a portion of the single-chain u-PA (scu-PA) intri
nsic to blood is tightly associated with platelets. Therefore, plasmin
ogen activation by platelet-associated u-PA was studied. When washed p
latelets were incubated with plasminogen, no plasmin was generated as
detected by plasmin synthetic substrate (S2403) hydrolysis; however, a
fter the addition of thrombin, but not other agonists, platelet-depend
ent plasminogen activation occurred. Plasminogen activation was surfac
e-related, being inhibited by blocking platelet fibrinogen receptors o
r by preventing plasminogen binding to the thrombin-activated platelet
surface. U-PA was identified as the only plasminogen activator respon
sible and enrichment of platelets with exogenous scu-PA significantly
augmented plasminogen activation. These findings appeared paradoxical
because thrombin inactivates scu-PA. Indeed, zymograms showed inactiva
tion of sera-PA during the first hour of incubation with even the lowe
st dose of thrombin used (1 u/mL). However, this was followed by a thr
ombin dose-dependent (1 to 10 u/mL) partial return of u-PA activity. R
eactivation of u-PA was not due to the direct action of thrombin, but
required platelets and was found to be related to a platelet lysosomal
thiol protease, consistent with cathepsin C. In conclusion, a new pat
hway of plasminogen activation by platelet-associated endogenous or ex
ogenous scu-PA was demonstrated, which is specifically triggered by th
rombin activation of platelets. These findings may help explain uPA-me
diated physiological fibrinolysis and have implications for therapeuti
c thrombolysis with scu-PA. (C) 1997 by The American Society of Hemato
logy.